Navigation Links
National Campaign Shows Veterans Why "It's Worth the Fight" Against Advanced Prostate Cancer

BRIDGEWATER, N.J., Nov. 11, 2011 /PRNewswire/ -- This Veterans Day, November 11, 2011, marks the national launch of an educational campaign designed to show veterans that "It's Worth the Fight" against advanced prostate cancer. The campaign was created by Sanofi US in collaboration with Men's Health Network (MHN), Women Against Prostate Cancer (WAPC), and the Veterans Health Council (VHC).

"Men's Health Network is focused on men's health issues, which is why we were excited to work on this campaign about advanced prostate cancer with Sanofi, WAPC and VHC," said Scott Williams, vice president of MHN.  "Prostate cancer – and particularly advanced prostate cancer – is of special importance to Vietnam veterans because of their age and possible exposure to Agent Orange. This campaign urges them to summon the same resolve they used in the service of this country to find the support and treatments they need because their health is truly worth the fight. While our focus is on veterans, this message should resonate with all men facing this disease."

"It's Worth the Fight" began with an educational event for veterans and their families at the Washington DC VA Medical Center. The event was recorded and may now be viewed by veterans across the U.S. through a webcast released in conjunction with Veterans Day. The webcast is accessible via the websites of MHN (, WAPC (, and the VHC ( alongside a Self-Assessment and Discussion Guide designed to help men monitor and talk to their healthcare team about their prostate health, their overall health, and their treatment options.

Featuring presentations by a medical expert as well as representatives of MHN, WAPC, and VHC, the "It's Worth the Fight" webcast provides information about advanced prostate cancer, its treatment and available support and resources, while emphasizing the importance of following the "three C's":

  • Communicate as your prostate cancer advances:
  • You're not alone – there are steps you can take to cope with advanced prostate cancer.
  • Be proactive and talk to your family. Use your family as a resource to educate yourself about the disease and your options.
  • Consult a team of health professionals:
  • Working with a multidisciplinary team (MDT) of experts – including your urologist, medical oncologist, radiation oncologist and other healthcare professionals – you can help improve treatment outcomes.
  • Consider all your options:
  • There are several treatment options available to you, even if your prostate cancer is in the advanced stages, and it's important to consider them all with your MDT to determine what's right for you.

  • "In my practice I have seen many men with advanced prostate cancer who don't realize there are more options for them. In fact, there have been advances in several therapeutic areas for the treatment of advanced disease, including chemotherapy," said Nancy A. Dawson, MD, the William M. Scholl Professor of Medicine and Oncology and director of Genito-Urinary Medical Oncology at the Lombardi Cancer Center at Georgetown University in Washington, D.C. "That's why it's critical for men not to give up the fight and to consider all their treatment options with their oncologist, urologist and other important members of their healthcare team."

    "Sanofi US created this educational initiative as part of the company's ongoing commitment to fighting advanced prostate cancer," said Charles Hugh-Jones, M.D., Vice President, Head of Medical Affairs Oncology, Sanofi North America. "Through 'It's Worth the Fight,' our goal is to help provide veterans and men in general with the information they need to talk about and confront this disease."

    To view the video webcast and other downloadable assets, please visit:

    About Advanced Prostate Cancer Prostate cancer affects nearly one in every six men in the United States. Among American men, prostate cancer is the second-leading cause of cancer-related death, resulting in more than 33,000 deaths annually. Only lung cancer kills more men with cancer.  According to the National Cancer Institute, 15 percent of men diagnosed with prostate cancer have advanced or metastatic disease.

    It's Worth the Fight"It's Worth the Fight" is a program designed to shine a light on the special needs of men with advanced prostate cancer. The educational webcast is a continuation of the program, which was launched with a live event at the Washington, D.C. VA Medical Center on October 3rd, 2011. While the program specifically targets veterans, it is relevant for all men at risk of or living with advanced prostate cancer. The campaign calls upon men with prostate cancer and advanced disease (along with the women and family members and friends in their lives) to summon their resolve to help themselves manage the disease.

    The program was created by Sanofi, which discovers and makes available oncology therapies for a variety of cancers, including prostate cancer.

    About Men's Health NetworkMen's Health Network (MHN) is a national non-profit organization whose mission is to reach men and their families where they live, work, play, and pray with health prevention messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation.

    Veterans Health Council and Advanced Prostate CancerAlmost two of every three cases of prostate cancer occur in men older than 65 years, making this disease of particular relevance to veterans, who are either a part of or will soon enter this age group. In a study of more than 13,000 Vietnam veterans, published in 2008, the authors concluded that those who were exposed to the herbicide Agent Orange had an increased risk of prostate cancer and an increased risk of metastatic prostate cancer, compared to those who were not exposed.

    The Veterans Health Council (VHC) aims to improve healthcare for veterans by creating an ongoing forum for members of the medical and clinical professions, employee representatives, advocacy organizations, and healthcare firms to discuss, develop, and promote effective efforts to:

  • inform veterans and their families about health issues and benefits available to them;
  • educate healthcare communities about the multiple health issues associated with military service;
  • develop materials on veterans' health issues for medical schools, nursing schools, teaching hospitals, and related educational outlets; and
  • support veterans' healthcare initiatives

  • About Women Against Prostate CancerWomen Against Prostate Cancer (WAPC) is a national organization working to unite the voices and provide support for the millions of women affected by prostate cancer, and their families. WAPC advocates prostate cancer education, public awareness, screenings, legislation, and treatment options.

    About Sanofi OncologyBased in Cambridge, Massachusetts, USA, and Vitry, France, Sanofi Oncology is dedicated to translating science into effective therapeutics to address unmet medical needs for cancer and organ transplant patients.  Starting with a deep understanding of the disease and the patient, Sanofi Oncology employs innovative approaches to drug discovery and clinical development, with the ultimate goal of bringing the right medicines to the right patients to help them live healthier and longer lives.  We believe in the value of partnerships that combine our internal scientific expertise with that of industry and academic experts.  Our portfolio includes 11 marketed products and more than 15 investigational compounds in clinical development, including small molecules and biological agents.

    About SanofiSanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

    Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US, also referred to as Sanofi-aventis U.S. LLC. For more information on Sanofi US, please visit or call 1-800-981-2491.Contacts:Director, Product Communications (U.S.)Corporate Media RelationsJeanne Longo

    Jack CoxTel: +1 (908) 981-6576

    Tel: +1 (908) 981-5280Mobile: +1 (201) 572-1116

    Mobile: +1 (908) 838-1443  E-mail:


    SOURCE sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
    3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
    4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
    6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
    7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
    8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
    9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
    10. September is National Pain Awareness Month
    11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
    Post Your Comments:
    (Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
    (Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
    (Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
    Breaking Medicine Technology:
    (Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
    (Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
    (Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
    (Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
    (Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: ...
    Breaking Medicine News(10 mins):